Zofran

Zofran (Ondansetron): During Pregnancy Linked to Heart Defects, Oral Facial Clefts & Other Congenital Malformations. Zofran During Pregnancy Parents of children with heart abnormalities, cleft palates and other birth defects should know that Zofran has been linked with these defects.  The Federal Food and Drug Administration has warned that the use of Zofran […]

Continue reading

Xarelto

ISSUE: Xarelto (rivaroxaban) is a blood-thinning drug (anti-coagulant) that has been linked to hundreds of injuries and deaths since it was approved in 2011. BACKGROUND: Xarelto (rivaroxaban) is a blood-thinning drug (anticoagulant) that is used to treat blood clots, deep vein thrombosis (DVT), and pulmonary embolisms. It has been sold […]

Continue reading

Diflucan

Diflucan (fluconazole): Drug Safety Communication – Long-term, High-dose Use During Pregnancy May Be Associated With Birth Defects ISSUE: FDA is informing the public that treatment with chronic, high doses (400-800mg/day) of Diflucan (fluconazole) during the first trimester of pregnancy may be associated with a rare and distinct set of birth […]

Continue reading

Topamax

Topamax (topiramate): Drug Safety Communication – During Pregnancy Linked to Oral Birth Defect Cleft Lip & Cleft Palate Topamax During Pregnancy Parents of children born with cleft palate or cleft lip need to know the drug Topamax has been linked to these birth defects. On March 4, 2011, the Federal […]

Continue reading